Results 181 to 190 of about 44,008 (229)

Real-world outcomes of faricimab in treating diabetic macular edema up to two years. [PDF]

Indian J Ophthalmol
Khetan T, Shah P, Ahmed S, Jeyabaladevan P, Vithlani S.   +4 more
europepmc   +1 more source

Positive Predictive Values of ICD-10-CM Diagnostic Codes in Identifying Diabetic Macular Edema in Claims Data: A Multi-Institutional Study in Taiwan. [PDF]

Clin Epidemiol
Huang YC, Hwang YS, Wu WC, Lai CC, Yeung L, Shao SC.   +5 more
europepmc   +1 more source

Refractory diabetic macular edema.

Journal of ophthalmic & vision research, 2010
openaire   +2 more sources

Anatomical and Systemic Predictors of Early Response to Subthreshold Micropulse Laser in Diabetic Macular Edema: A Retrospective Cohort Study. [PDF]

J Clin Med
Gagliardi OM, Gregori G, Muzi A, Mangoni L, Mogetta V, Chhablani J, Pompucci G, Rizzo C, Iannetta D, Mariotti C, Lupidi M.   +10 more
europepmc   +1 more source

Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study). [PDF]

Clin Ophthalmol
Chakraborty S, Sheth JU, Ganguly S, Reddy R.   +3 more
europepmc   +1 more source

Cataract surgery and the risk of developing recurrence or progression of diabetic macular edema. [PDF]

PLoS One
Kim M, Park YG, Park YH.
europepmc   +1 more source

Changes in the macrophage-like cells following progression and treatment of diabetic macular edema. [PDF]

Indian J Ophthalmol
Sathishkumar S, Ratra D.
europepmc   +1 more source

Early Switch to Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema Poorly Responding to Anti-VEGF Therapy: A Narrative Review. [PDF]

Ophthalmol Ther
Sacconi R, Scarinci F, Grassi MO, Covello G, Lo Giudice G, De Siena E, Cacace V, Gallinaro V, Dell'Omo R.   +8 more
europepmc   +1 more source

Persistent Vision Loss of Eyes Lost to Follow-Up with Diabetic Macular Edema Receiving Intravitreal Anti-VEGF Therapy. [PDF]

Ophthalmol Sci
Zhou C, Shen Y, Li S, Li Y, Zhu D, Li X, Yang X, Xu Y, Wang X, Cao N, Sun D, Zhang W, Li S, Zhang H, Lv H, Ma X, Yu H, Song Z, Zhang T, Yu X, Liu Y, Niu T, Yuan R, You Z, Liu Q, Song Y, Sun X, Zheng Z, Liu K, Xu X.   +29 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diabetic macular edema

Disease-a-Month, 2021
Diabetic retinopathy (DR) is a leading cause of preventable blindness world-wide. Diabetic macular edema (DME) is the most common cause of moderate vision loss in patients with diabetes. Although treatments for DME have improved significantly over the past decades, the burden of this disease remains high for patients and the healthcare system alike ...
Melissa, Ixcamey, Camille, Palma
openaire   +4 more sources